SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-004539
Filing Date
2019-04-01
Accepted
2019-04-01 16:33:26
Documents
78
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 2474744
2 image_001.jpg GRAPHIC 9700
3 ex10-39.htm EX-10.39 132730
4 ex10-44.htm EX-10.44 168858
5 ex10-45.htm EX-10.45 268478
6 ex10-46.htm EX-10.46 121084
7 ex21-1.htm EX-21.1 3696
8 ex31-1.htm EX-31.1 18648
9 ex31-2.htm EX-31.2 18673
10 ex32-1.htm EX-32.1 11392
  Complete submission text file 0001493152-19-004539.txt   9215553

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE obmp-20181231.xml EX-101.INS 1202533
12 XBRL SCHEMA FILE obmp-20181231.xsd EX-101.SCH 82726
13 XBRL CALCULATION FILE obmp-20181231_cal.xml EX-101.CAL 83080
14 XBRL DEFINITION FILE obmp-20181231_def.xml EX-101.DEF 321728
15 XBRL LABEL FILE obmp-20181231_lab.xml EX-101.LAB 592621
16 XBRL PRESENTATION FILE obmp-20181231_pre.xml EX-101.PRE 443711
Mailing Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809
Business Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809 225-227-2384
OncBioMune Pharmaceuticals, Inc (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52218 | Film No.: 19721155
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences